Brief: Australian Clinical Labs Says Stephen Roche To Become Chair On 26 Aug
20/06/2025 24:40
June 20 (Reuters) - Australian Clinical Labs Ltd ACL.AX: STEPHEN ROCHE TO BECOME CHAIR OF BOARD ON 26 AUGUST MARK HABERLIN TO CONTINUE AS INTERIM CHAIR UNTIL 26 AUGUST 2025 Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million